Teva.ie valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Teva Ireland |
| Description | A leading provider of medicines to the Irish health service, enabling millions of patients in Ireland to live better days |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.155.76 |
| Location | United States |
Related Websites
| Site | Rank |
| tevacanada.com | #1,749,767 |
More to Explore
Teva.ie Valuation
|
US$28,976
Last updated: Oct 15, 2021
Teva.ie has global traffic rank of 594,266. Its global rank has gone up by 315,493 positions since 3 months ago. Teva.ie has an estimated worth of US$ 28,976, based on its estimated Ads revenue. Teva.ie receives approximately 5,292 unique visitors each day. Its web server is located in United States, with IP address 45.60.155.76. According to SiteAdvisor, teva.ie is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$28,976 |
| Daily Ads Revenue | US$15 |
| Monthly Ads Revenue | US$476 |
| Yearly Ads Revenue | US$5,795 |
| Daily Unique Visitors | 5,292 |
| Note: All traffic and earnings values are estimates. | |
Traffic Ranks
| Global Rank | 594,266 |
| Delta (90 Days) | ⬆️ 315,493 |
| Most Popular In Country | N/A |
| Country Rank | N/A |
DNS Records
| Host | Type | TTL | Data |
| teva.ie | A | 21600 | IP: 45.60.167.76 |
| teva.ie | A | 21600 | IP: 45.60.155.76 |
| teva.ie | MX | 21600 | Priority: 10 Target: mx02.tevapharm.com. |
| teva.ie | MX | 21600 | Priority: 10 Target: mx01.tevapharm.com. |
| teva.ie | NS | 21600 | Target: ns3.tevapharm.com. |
| teva.ie | NS | 21600 | Target: ns5.tevapharm.com. |
| teva.ie | NS | 21600 | Target: ns4.tevapharm.com. |
| teva.ie | TXT | 21600 | TXT: docusign=d42d07b0-ba6f-4a0d-83b5-3ba643c19e9a |
| teva.ie | TXT | 21600 | TXT: v=spf1 include:_spf.mail.teva include:spf.protection.outlook.com ~all |
| teva.ie | TXT | 21600 | TXT: _globalsign-domain-verification=-mrCDIV71wAl5ZEI_KNjAQkTP909CIi-uVPaygQrSE |
| teva.ie | TXT | 21600 | TXT: MS=ms51852403 |
| teva.ie | TXT | 21600 | TXT: docusign=69b5bc09-0153-4d3e-912f-adc16efd7529 |
| teva.ie | SOA | 21600 | MNAME: ns3.tevapharm.com. RNAME: domainadmincorp.teva.co.il. Serial: 2011032121 Refresh: 10800 Retry: 3600 Expire: 2592000 Minimum TTL: 86400 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.teva.ie/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: private content-type: text/html; charset=utf-8 set-cookie: ASP.NET_SessionId=yrif2awtgqbaruzy55r0juvz; path=/; HttpOnly; SameSite=Lax request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081 access-control-expose-headers: Request-Context x-powered-by: ASP.NET x-frame-options: DENY date: Fri, 15 Oct 2021 05:04:16 GMT set-cookie: visid_incap_1932989=E7RQEE4qSUSPIKvi043dzM8LaWEAAAAAQUIPAAAAAAAP1vMSbJZSzwyOKl0ESFmg; expires=Fri, 14 Oct 2022 06:40:52 GMT; HttpOnly; path=/; Domain=.teva.ie set-cookie: nlbi_1932989=1hWBDNs2CFM09S+2vhyytwAAAACJgxFxjGX4WVGyx4dJCsiy; path=/; Domain=.teva.ie set-cookie: incap_ses_1462_1932989=h9DpJMDnWlOmFEKtUxFKFNALaWEAAAAAuseKCiTOG34aCnS4dUpFXw==; path=/; Domain=.teva.ie x-cdn: Imperva x-iinfo: 12-90561919-90561920 NNNN CT(11 26 0) RT(1634274255814 0) q(0 0 0 0) r(4 4) U12 |
Teva.ie Whois Information
Domain Name: teva.ie Registry Domain ID: 587339-IEDR Registrar WHOIS Server: whois.weare.ie Registrar URL: http://www.comlaude.com/ Updated Date: 2021-09-02T15:11:28Z Creation Date: 2001-07-18T23:00:00Z Registry Expiry Date: 2022-07-19T15:09:49Z Registrar: Com Laude Registrar IANA ID: not applicable Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +44.2074218250 Domain Status: ok https://icann.org/epp#ok Registry Registrant ID: 260854-IEDR Registrant Name: Teva Pharmaceutical Industries Limited Registry Admin ID: 84647-IEDR Registry Tech ID: 84647-IEDR Registry Billing ID: REDACTED FOR PRIVACY Name Server: ns3.tevapharm.com Name Server: ns4.tevapharm.com Name Server: ns5.tevapharm.com DNSSEC: unsigned |